D-telaprevir
Side effects
Options:
Hide MedDRA Preferred Terms
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
Asthenia
|
Fatigue
|
50%
|
|
x
|
|
|
Fatigue
|
Fatigue
|
50%
|
|
x
|
|
|
Dermatitis
|
Rash
|
very common, 34%
|
|
x
|
x
|
x
|
Rash
|
Rash
|
very common, 34%
|
|
x
|
x
|
x
|
Pruritus
|
Pruritus
|
very common, 28%
|
|
x
|
x
|
x
|
Anaemia
|
Anaemia
|
17%
|
|
x
|
x
|
x
|
Nausea
|
Nausea
|
common, 28%
|
|
x
|
x
|
x
|
Diarrhoea
|
Diarrhoea
|
common, 17%
|
|
x
|
x
|
x
|
Vomiting
|
Vomiting
|
common, 8%
|
|
x
|
x
|
x
|
Eczema
|
Eczema
|
common
|
|
|
x
|
x
|
Proctalgia
|
Proctalgia
|
common
|
|
|
x
|
x
|
Dizziness
|
Syncope
|
common
|
|
|
x
|
x
|
Shock
|
Syncope
|
common
|
|
|
x
|
x
|
Syncope
|
Syncope
|
common
|
|
|
x
|
x
|
Loss of consciousness
|
Syncope
|
common
|
|
|
x
|
x
|
Dysgeusia
|
Dysgeusia
|
common, 3%
|
|
x
|
x
|
x
|
Haemorrhoids
|
Haemorrhoids
|
common, 3%
|
|
x
|
x
|
x
|
Anal pruritus
|
Anal pruritus
|
common, 1%
|
|
x
|
x
|
x
|
Pruritus genital
|
Anal pruritus
|
common, 1%
|
|
x
|
x
|
x
|
Anorectal discomfort
|
Anal pruritus
|
common, 1%
|
|
x
|
x
|
x
|
Anorectal discomfort
|
3%
|
|
x
|
x
|
x
|
Burning rectal
|
|
|
x
|
x
|
x
|
Candida infection
|
Oral candidiasis
|
uncommon
|
|
|
x
|
x
|
Oral candidiasis
|
Oral candidiasis
|
uncommon
|
|
|
x
|
x
|
Drug eruption
|
Drug eruption
|
uncommon
|
|
|
x
|
x
|
Eosinophilia
|
Eosinophilia
|
uncommon
|
|
|
x
|
x
|
Anal fissure
|
Anal fissure
|
uncommon
|
|
|
x
|
x
|
Gout
|
Gout
|
uncommon
|
|
x
|
x
|
x
|
Gouty arthritis
|
|
|
x
|
|
|
Hypothyroidism
|
Hypothyroidism
|
uncommon
|
|
|
x
|
x
|
Proctitis
|
Proctitis
|
uncommon
|
|
|
x
|
x
|
Retinal disorder
|
Retinal disorder
|
uncommon
|
|
|
x
|
x
|
Urticaria
|
Urticaria
|
uncommon
|
|
|
x
|
x
|
Oedema peripheral
|
Oedema peripheral
|
uncommon
|
|
|
x
|
x
|
Swelling face
|
Swelling face
|
uncommon
|
|
|
x
|
x
|
Rectal haemorrhage
|
Rectal haemorrhage
|
uncommon
|
|
|
x
|
x
|
Exfoliative rash
|
Exfoliative rash
|
uncommon
|
|
|
x
|
x
|
Toxic epidermal necrolysis
|
Toxic epidermal necrolysis
|
postmarketing
|
|
x
|
x
|
|
Erythema multiforme
|
Erythema multiforme
|
postmarketing
|
|
x
|
x
|
x
|
Stevens-Johnson syndrome
|
|
|
|
x
|
|
Urethral disorder
|
Urinary tract disorder
|
postmarketing
|
|
x
|
|
x
|
Urinary tract disorder
|
Urinary tract disorder
|
postmarketing
|
|
x
|
|
x
|
Skin disorder
|
Unspecified disorder of skin and subcutaneous tissue
|
postmarketing
|
|
x
|
x
|
x
|
Skin disorder
|
|
|
x
|
|
|
Acute prerenal failure
|
Azotemia prerenal
|
postmarketing
|
|
x
|
|
x
|
Renal failure acute
|
Acute renal insufficiency
|
postmarketing
|
|
x
|
|
|
Renal failure acute
|
|
|
|
|
x
|
Urate nephropathy
|
Urate nephropathy
|
postmarketing
|
|
x
|
|
|
Acquired immunodeficiency syndrome
|
Acquired immunodeficiency syndrome
|
|
|
|
x
|
x
|
Autoimmune disorder
|
Acquired immunodeficiency syndrome
|
|
|
|
x
|
x
|
Gouty arthritis
|
Gouty arthritis
|
|
|
x
|
|
|
Infection
|
Infection
|
|
|
|
x
|
x
|
Endocrine disorder
|
Endocrine disorder
|
|
|
|
x
|
x
|
Eye disorder
|
Eye disorder
|
|
|
|
x
|
x
|
Gastrointestinal disorder
|
Gastrointestinal disorder
|
|
|
|
x
|
x
|
Hyperbilirubinaemia
|
Hyperbilirubinaemia
|
|
|
|
x
|
x
|
Hypokalaemia
|
Hypokalaemia
|
|
|
|
x
|
x
|
Lymphopenia
|
Lymphopenia
|
|
|
|
x
|
x
|
Nervous system disorder
|
Nervous system disorder
|
|
|
|
x
|
x
|
Pregnancy
|
Pregnancy
|
|
|
x
|
|
|
Stevens-Johnson syndrome
|
Stevens-Johnson syndrome
|
|
|
|
x
|
|
Thrombocytopenia
|
Thrombocytopenia
|
|
|
|
x
|
x
|
Blood uric acid increased
|
Uric acid level increased
|
|
|
x
|
|
|
Hyperuricaemia
|
|
|
|
x
|
x
|
Raised serum uric acid
|
|
|
|
x
|
x
|
Malnutrition
|
Malnutrition
|
|
|
|
x
|
x
|
Blood creatinine increased
|
Blood creatinine increased
|
|
|
|
x
|
x
|
Hepatobiliary disease
|
Hepatobiliary disease
|
|
|
|
|
x
|
Hyperuricaemia
|
Hyperuricaemia
|
|
|
|
x
|
x
|
Infestation
|
Infestation NOS
|
|
|
|
x
|
x
|
Product taste abnormal
|
Product taste abnormal
|
|
|
|
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 24 |
Source: | FDA Structured Product Label |
---|
Side effects: | 47 |
Source: | Medsafe |
---|
Side effects: | 50 |
Source: | EMA |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|